Literature DB >> 25368827

The first Korean case of childhood acute myeloid leukemia with inv(11)(p15q22)/NUP98-DDX10 rearrangement: a rare but recurrent genetic abnormality.

Rihwa Choi1, Mi-Ae Jang1, Keon Hee Yoo2, Seung-Tae Lee1, Hee-Jin Kim1, Sun-Hee Kim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25368827      PMCID： PMC4215408          DOI： 10.3343/alm.2014.34.6.478

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN： 2234-3806            Impact factor:   3.464


× No keyword cloud information.
  10 in total

1.  The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts.

Authors:  T Ikeda; K Ikeda; K Sasaki; K Kawakami; J Takahara
Journal:  Int J Hematol       Date:  1999-04       Impact factor: 2.490

Review 2.  Inversion (11)(p15q22) with NUP98-DDX10 fusion gene in pediatric acute myeloid leukemia.

Authors:  Cristina Morerio; Maura Acquila; Annamaria Rapella; Elisa Tassano; Cristina Rosanda; Claudio Panarello
Journal:  Cancer Genet Cytogenet       Date:  2006-12

Review 3.  Nucleoporins and nucleocytoplasmic transport in hematologic malignancies.

Authors:  Akiko Takeda; Nabeel R Yaseen
Journal:  Semin Cancer Biol       Date:  2014-03-18       Impact factor: 15.707

4.  NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

Authors:  Iris H I M Hollink; Marry M van den Heuvel-Eibrink; Susan T C J M Arentsen-Peters; Marta Pratcorona; Saman Abbas; Jenny E Kuipers; Janneke F van Galen; H Berna Beverloo; Edwin Sonneveld; Gert-Jan J L Kaspers; Jan Trka; Andre Baruchel; Martin Zimmermann; Ursula Creutzig; Dirk Reinhardt; Rob Pieters; Peter J M Valk; C Michel Zwaan
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

5.  The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10.

Authors:  Y Arai; F Hosoda; H Kobayashi; K Arai; Y Hayashi; N Kamada; Y Kaneko; M Ohki
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

6.  Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia.

Authors:  Masahide Yamamoto; Kazuhiko Kakihana; Tetsuya Kurosu; Naomi Murakami; Osamu Miura
Journal:  Cancer Genet Cytogenet       Date:  2005-03

7.  Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.

Authors:  Karin Nebral; Margit König; Helmut H Schmidt; Dieter Lutz; Wolfgang R Sperr; Krzysztof Kalwak; Stefan Brugger; Michael N Dworzak; Oskar A Haas; Sabine Strehl
Journal:  Haematologica       Date:  2005-06       Impact factor: 9.941

8.  Inv(11)(p15q22)/NUP98-DDX10 fusion and isoforms in a new case of de novo acute myeloid leukemia.

Authors:  Paolo Gorello; Valeria Nofrini; Lucia Brandimarte; Valentina Pierini; Barbara Crescenzi; Filomena Nozza; Giulia Daniele; Clelia Tiziana Storlazzi; Danika Di Giacomo; Caterina Matteucci; Roberta La Starza; Cristina Mecucci
Journal:  Cancer Genet       Date:  2013-03-20

9.  Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.

Authors:  E R Yassin; A M Abdul-Nabi; A Takeda; N R Yaseen
Journal:  Leukemia       Date:  2010-03-25       Impact factor: 11.528

10.  NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.

Authors:  S P Romana; I Radford-Weiss; R Ben Abdelali; C Schluth; A Petit; N Dastugue; P Talmant; C Bilhou-Nabera; F Mugneret; M Lafage-Pochitaloff; M-J Mozziconacci; J Andrieu; J-L Lai; C Terre; K Rack; P Cornillet-Lefebvre; I Luquet; N Nadal; F Nguyen-Khac; C Perot; J Van den Akker; S Fert-Ferrer; C Cabrol; C Charrin; I Tigaud; H Poirel; M Vekemans; O A Bernard; R Berger
Journal:  Leukemia       Date:  2006-04       Impact factor: 11.528
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.